Albers MW, Liu J, Schreiber SL. Relationship of FKBP to PKCI-2. Nature. 1991;351(6327):527. doi:10.1038/351527c0
Brauner A, Shoresh N, Fridman O, Balaban NQ. An Experimental Framework for Quantifying Bacterial Tolerance. Biophys J. 2017;112(12):2664-2671. doi:10.1016/j.bpj.2017.05.014
Soto M, Herzog C, Pacheco JA, et al. Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism. Mol Psychiatry. 2018;23(12):2287-2301. doi:10.1038/s41380-018-0086-5
Michnick SW, Rosen MK, Wandless TJ, Karplus M, Schreiber SL. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin. Science. 1991;252(5007):836-9.
Verderosa AD, de la Fuente-Núñez C, Mansour SC, et al. Ciprofloxacin-nitroxide hybrids with potential for biofilm control. Eur J Med Chem. 2017;138:590-601. doi:10.1016/j.ejmech.2017.06.058
Munschauer M, Vogel J. Nuclear lncRNA stabilization in the host response to bacterial infection. EMBO J. 2018;37(13). doi:10.15252/embj.201899875
Bierer BE, Somers PK, Wandless TJ, Burakoff SJ, Schreiber SL. Probing immunosuppressant action with a nonnatural immunophilin ligand. Science. 1990;250(4980):556-9.
Ma P, Laibinis HH, Ernst CM, Hung DT. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate. Antimicrob Agents Chemother. 2018;62(11). doi:10.1128/AAC.01281-18
Gilmore MS, Salamzade R, Selleck E, et al. Genes Contributing to the Unique Biology and Intrinsic Antibiotic Resistance of Enterococcus faecalis. mBio. 2020;11(6). doi:10.1128/mBio.02962-20
Rosen MK, Standaert RF, Galat A, Nakatsuka M, Schreiber SL. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. Science. 1990;248(4957):863-6.